Form4insider filings, from the source

SEC Form 4 · accession 0001225208-18-002947

JOHNSON & JOHNSON · JNJ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Joaquin Duato
Officer — Exec VP, WW Chair, Pharma
Period of report
Feb 12, 2018
Accepted (ET)
Feb 14, 2018 · 6:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000200406

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 12, 2018M24,530$0.00A99,210D
Common StockF2Feb 12, 2018A8,831$0.00A108,041D
Common StockF3Feb 12, 2018F14,486$129.51D93,555D
Common StockF4holding———602IBy 401k

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Options (Right to Buy)F5$129.51Feb 12, 2018A105,307AFeb 12, 2021Feb 12, 2028Common Stock105,307105,307D
Performance Share UnitsF1$0.00Feb 12, 2018M24,530DFeb 9, 2018—Common Stock24,5300D
Restricted Share UnitsF6—Feb 12, 2018A5,283AFeb 12, 2021—Common Stock5,2835,283D

Explanation of responses